Through surface modification technology, antibodies for CA125 and HER2 were immobilized on the silicon pillar array, enabling the sensor to specifically recognize and bind to the target tumor markers, thereby significantly improving the specificity and sensitivity of the detection. The gene discussed is ERBB2; the disease is neoplasm.